Treatment for COVID-19 in High-Risk Adult Outpatients
Status:
Active, not recruiting
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
This is a randomized trial for the treatment of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection in high-risk adults not requiring hospital admission.The overarching
goal of this study is to assess the effectiveness of interventions on the incidence of lower
respiratory tract infection (LRTI) progression among high-risk adult outpatients with
SARS-CoV-2 infection to inform public health control strategies.